Abstract
Cancer is a growing global burden; there were an estimated 18 million new cancer diagnoses worldwide in 2020. Excisional surgery remains one of the main treatments for solid organ tumours in cancer patients and is potentially curative. Cancer- and surgery-induced inflammatory processes can facilitate residual tumour cell survival, growth, and subsequent recurrence. However, it has been hypothesised that anaesthetic and analgesic techniques during surgery might influence the risk of cancer recurrence. This narrative review aims to provide an updated summary of recent observational studies and new randomised controlled clinical trials on whether certain specific anaesthetic and analgesic techniques or perioperative interventions during tumour resection surgery of curative intent materially affect long-term oncologic outcomes.
Original language | English |
---|---|
Pages (from-to) | 989-1001 |
Number of pages | 13 |
Journal | British Journal of Anaesthesia |
Volume | 131 |
Issue number | 6 |
Early online date | 11 Nov 2023 |
DOIs | |
Publication status | Published - 1 Dec 2023 |
Keywords
- general anaesthesia
- intravenous anaesthesia
- metastasis cancer
- opioid cancer
- postoperative analgesia
- recurrence cancer
- regional analgesia
- surgery